Taylor Wealth Management Partners’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Taylor Wealth Management Partners’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33,877	Closed	-$574K	–	74
2021 Q2	$574K	Sell	33,877 -2,484	-7%	-$47.1K	0.2%	50
2021 Q1	$954K	Buy	36,361 +12,522	+53%	+$569K	0.35%	52
2020 Q4	$862K	Sell	23,839 -8,519	-26%	-$308K	0.33%	47
2020 Q3	$1.15M	Buy	32,358 +52	+0.2%	+$2.26K	0.52%	39
2020 Q2	$1.37M	Sell	32,306 -2,045	-6%	-$138K	0.7%	38
2020 Q1	$2.74M	Sell	34,351 -938	-3%	-$75.1K	1.68%	23
2019 Q4	$3.27M	Sell	35,289 -113	-0.3%	-$9.54K	1.5%	26
2019 Q3	$2.68M	Sell	35,402 -105	-0.3%	-$8.06K	1.25%	26
2019 Q2	$3.54M	Buy	35,507 +50	+0.1%	+$3.87K	1.65%	24
2019 Q1	$1.86M	Sell	35,457 -140	-0.4%	-$7.58K	0.93%	28
2018 Q4	$2.24M	Sell	35,597 -303	-0.8%	-$16.7K	1.29%	25
2018 Q3	$2.18M	Buy	35,900 +17,319	+93%	+$750K	0.93%	33
2018 Q2	$755K	Buy	+18,581	New	+$1.46M	0.34%	41

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Taylor Wealth Management Partners's EVFM Position: Q3 2021 in Review

Taylor Wealth Management Partners sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2021, closing a stake of 33,877 shares — an estimated $574K sold.

Taylor Wealth Management Partners first reported a position in EVFM in Q2 2018 and held it in 13 quarters. The position peaked at $3.54M in Q2 2019. 71 funds tracked by Wall St. Rank hold EVFM as of Q3 2021.

Taylor Wealth Management Partners reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Taylor Wealth Management Partners sold 33,877 Evofem Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $574K.
Taylor Wealth Management Partners first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
Taylor Wealth Management Partners's Evofem Biosciences, Inc. Common Stock position peaked at $3.54M in Q2 2019.
71 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2021.

Based on Taylor Wealth Management Partners's 13F filing for Q3 2021, filed 26 Oct 2021.